SCHEMBL221108

SCHEMBL221108

O=C(c1ccccc1)C(C(=O)c1ccccc1)C(C[N+](=O)[O-])c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
CES2 O00748 1/20 0.51
CES1 P23141 1/20 0.51
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
POLB P06746 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
MITF O75030 1/20 0.46
MAPK1 P28482 1/20 0.44
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
BCHE P06276 1/20 0.43
MAOB P27338 1/20 0.43
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL221107 1.00 ALDH1A1 (0.53) ALDH1A1CES2CES1KMT2AMEN1
SCHEMBL221352 0.90 TDP1 (0.47) ALDH1A1CES2CES1NPC1RAB9A
SCHEMBL221353 0.90 TDP1 (0.47) ALDH1A1CES2CES1NPC1RAB9A
SCHEMBL220114 0.86 CNR1 (0.43) ALDH1A1CES2CES1KMT2AMEN1
SCHEMBL220113 0.86 CNR1 (0.43) ALDH1A1CES2CES1KMT2AMEN1
SCHEMBL221507 0.86 LMNA (0.43) ALDH1A1CES2CES1KMT2AMEN1
SCHEMBL221508 0.86 LMNA (0.43) ALDH1A1CES2CES1KMT2AMEN1
SCHEMBL221213 0.86 LMNA (0.43) ALDH1A1CES2CES1KMT2AMEN1
SCHEMBL221212 0.86 LMNA (0.43) ALDH1A1CES2CES1KMT2AMEN1
SCHEMBL6249908 0.84 CPA1 (0.46) ALDH1A1CES2CES1NPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8940938-B2 Michael reaction with recovery of the catalyst NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2015-01-27 US disclosed
US-20120004424-A1 MICHAEL REACTION WITH RECOVERY OF THE CATALYST NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004424-A1 MICHAEL REACTION WITH RECOVERY OF THE CATALYST CYP2E1, CYP11B2, CYP11B1 ALDH1A1 118/4885CES2 379/4885CES1 1151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.